Regulatory Goes Digital: Chapter 5 in Our Series on Drug Development Data
In the final chapter of our series, Yash dives into one of the biggest upcoming shifts in drug development’s data paradigm: moving to structured, cloud-based regulatory submissions.
Welcome, Joschka Buyel: Longtime Customer, Now Our Director of Product Management
Joschka’s role will be a new chapter in his career as a multi-modal CMC expert—as well as a whole new way to apply his first-hand experience deploying and using our product.
Enabling Pre-commercial Product Lifecycle Management (PLM) for Pharma & Biotech
For drug developers, pre-commercial product lifecycle management (PLM) is quickly becoming essential for regulatory compliance and operational efficiency. Learn how digital CMC tools can enable it.
Getting Leaner, Going Digital: 4 Ways Drug Developers Are Adapting to a New Market
Drug developers are downsizing their way into a new era of efficiency. Here’s why they need digital infrastructure like QbDVision more than ever.
New Updates to the FDA’s PAI Process Put Drug Developers on Notice
With the new CPMG Objective 4, the FDA has officially put knowledge management and QRM on the menu for PAI audits. So what does that mean for drug development programs?
Interview: Mike Stapleton Outlines His Vision for the Next Frontier of Digital Drug Development
A distinguished life science leader with more than 30 years of experience, Mike brings a wealth of expertise and a track record of success to his new board leadership role.